| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | $10.0650 | +0.25% | $317.37M | $104.23K | |
FUND Sprott Focus Trust, Inc. | $10.9300 | +0.46% | $317.19M | $8.94K | |
FATE Fate Therapeutics, Inc. | $2.4500 | +5.15% | $317.04M | $1.31M | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1.5250 | -6.44% | $316.83M | $1.15M | |
GALT Galectin Therapeutics Inc. | $3.8750 | +5.30% | $316.66M | $227.62K | |
NREF NexPoint Real Estate Finance, Inc. | $17.8500 | +4.51% | $316.64M | $47.50K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10.8100 | -0.19% | $316.34M | $1.31K | |
PSBD Palmer Square Capital BDC Inc. | $10.3800 | +1.07% | $316.32M | $55.62K | |
| $3.1100 | -4.01% | $316.09M | $457.11K | |
| $6.4300 | -0.62% | $315.88M | $95.99K | |
SMTI Sanara MedTech Inc. Common Stock | $34.3900 | -0.17% | $315.59M | $460.11K | |
MLP Maui Land & Pineapple Co. | $15.7600 | +0.64% | $315.56M | $19.27K | |
AFB Alliance National Municipal Income Fund, Inc. | $10.9300 | +0.18% | $315.33M | $19.91K | |
| $41.0200 | +0.05% | $315.30M | $14.39K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10.5400 | +0.05% | $315.30M | $71.01K | |
